These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8718568)

  • 1. Mechanisms of cardiovascular injury in renal disease.
    Rabelink TJ; Stroes ES; Koomans HA
    Blood Purif; 1996; 14(1):67-74. PubMed ID: 8718568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lipid metabolism and atherosclerosis risk in renal diseases in pediatric age].
    Ferrara P; Ruggiero A; Pulitanò S; Vacca P; Venuti L; Salvaggio E
    Minerva Pediatr; 1998 Dec; 50(12):513-8. PubMed ID: 10210942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyslipidemia in renal disease.
    Mittman N; Avram MM
    Semin Nephrol; 1996 May; 16(3):202-13. PubMed ID: 8734463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipid anomalies during renal insufficiency: consequences on the progression of renal insufficiency and cardiovascular risk].
    Moulin B
    Nephrologie; 2000; 21(7):339-41. PubMed ID: 11200605
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypertension, atherosclerosis and kidney].
    Zuccalà A; Fiorenza S; Rapanà R; Santoro A
    G Ital Nefrol; 2005; 22 Suppl 31():S9-14. PubMed ID: 15786409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and renal function.
    Elisaf M; Mikhailidis DP
    Angiology; 2002; 53(5):493-502. PubMed ID: 12365855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hyperlipidemia in human renal disease.
    D'Amico GD; Gentile MG
    Miner Electrolyte Metab; 1993; 19(3):196-204. PubMed ID: 8232107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperlipidemia and its management in renal disease.
    Massy ZA; Kasiske BL
    Curr Opin Nephrol Hypertens; 1996 Mar; 5(2):141-6. PubMed ID: 8744535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second International Symposium on Lipids, Atherosclerosis and the Kidney: summary of scientific presentations.
    Klahr S; D'Amico G
    Nephrol Dial Transplant; 1994; 9(11):1660-3. PubMed ID: 7870362
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic pathogenesis of cardiorenal disease.
    Keane WF
    Am J Kidney Dis; 2001 Dec; 38(6):1372-5. PubMed ID: 11728977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal insufficiency is an important cardiovascular risk factor].
    Pérez Flores I; Luño J
    Nefrologia; 2002; 22(4):306-9. PubMed ID: 12369120
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular disease risk factors and atherosclerosis in children and adolescents.
    Daniels SR
    Curr Atheroscler Rep; 2001 Nov; 3(6):479-85. PubMed ID: 11602068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine, lipoprotein(a) and fibrinogen: metabolic risk factors for cardiovascular complications of chronic renal disease.
    Kronenberg F
    Curr Opin Nephrol Hypertens; 1998 May; 7(3):271-8. PubMed ID: 9617557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephropathy subsequent to hyperlipidemia.
    Teuscher AU; Weidmann P; Lerch M; Laissue JA
    Clin Nephrol; 2000 Jul; 54(1):64-7. PubMed ID: 10939759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperinsulinemia and cardiovascular risk].
    Brunelli C; Spallarossa P; Cordera R; Caponnetto S
    Cardiologia; 1994 Dec; 39(12 Suppl 1):163-8. PubMed ID: 7634261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperinsulinemia and cardiovascular risk.
    Arrants J
    Heart Lung; 1994; 23(2):118-22; 123-4. PubMed ID: 8206768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyslipidemia in patients with type 2 diabetes. relationships between lipids, kidney disease and cardiovascular disease.
    Battisti WP; Palmisano J; Keane WE
    Clin Chem Lab Med; 2003 Sep; 41(9):1174-81. PubMed ID: 14598867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors of atherosclerosis in end-stage renal disease patients].
    Jono S
    Clin Calcium; 2004 Jan; 14(1):21-6. PubMed ID: 15576949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum of cardiovascular disease in children with predialysis chronic kidney disease.
    Chavers BM; Herzog CA
    Adv Chronic Kidney Dis; 2004 Jul; 11(3):319-27. PubMed ID: 15241746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.